Camilia® Oral Solution is a homeopathic medication that has been developed by Boiron Laboratories, a French leader in homeopathic medicine. Created in 1994, Camilia® was first distributed in Canada, then in the USA (from 1998) and, subsequently, in France (2003). Today, Camilia® is also available in Italy, Luxembourg, Poland, Russia, Switzerland and Tunisia. From May 2013, Camilia® will be available in Britain..
Camilia® treats infant teething pains as well as the related symptoms — crotchety behaviour, swollen gums, sore bottoms, red cheeks, profuse salivation, etc. Thanks to its exclusive formula, which combines three natural substances — Chamomilla vulgaris 9c, Phytolacca decandra 5c and Rheum 5c — and purified water, Camilia® has been the remedy of choice for infants from Canada to Tunisia since it was first developed in the mid-1990s.
Camilia® contains no artificial colouring, no preservatives, no sugars, no lactose and no ethanol. Besides, the pharmaceutical form taken by Camilia® — sterile, drinkable single doses, with a neutral taste — promotes hygiene and makes the administration of the medication to babies and other infants easy.
In France, since its launch in 2003, Camilia® has been adopted by millions of parents: over 50% of mothers are familiar with the product and, among those who administer it to their children, 94% are satisfied with it. [This data stems from a survey with 300 mothers of children aged six to 24 months, which was conducted by survey expert Toluna in November 2010.]
When it becomes available in Britain from May, Camilia® can be bought over the counter (i.e. without mandatory medical prescription) and will be available in both pharmacies and health food stores. Packaged in boxes of 10 single doses, Camilia® will be sold at the recommended retail price of £6.95 per box when launched.